The frequency of micronuclei in lymphocytes of dogs with osteosarcoma: A predictive variable for tumor response during cisplatin chemotherapy

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 8, 1996, Pages 653-656

  Hahn, Kevin A ^a   Legendre, Alfred M ^a   Talbott, James R ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE G0 PHASE; DOSE RESPONSE; DRUG RESPONSE; LYMPHOCYTE; MICRONUCLEUS; NONHUMAN; OSTEOSARCOMA; PREDICTION; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CISPLATIN; DNA DAMAGE; DNA, NEOPLASM; DOGS; G0 PHASE; LYMPHOCYTES; MICRONUCLEI, CHROMOSOME-DEFECTIVE; OSTEOSARCOMA; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 0029814179     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Fenech, M., and Morley, A. A. Measurement of micronuclei in lymphocytes. Mutat. Res., 147: 29-36, 1985.
2. Hahn, K. A., and Barnhill, M. A. Effect of hypoxia on the frequency of bleomycin-induced micronuclei. Oncol. Rep., in press, 1996.
3. Littlefield, L. G., Sayer, A. M., and Frome, E. L. Comparisons of dose-response parameters for radiation-induced acentric fragments and micronuclei observed in cytokinesis-arrested lymphocytes. Mutagenesis, 4: 265-270, 1989.
4. Hahn, K. A., and Barnhill, M. A. Hypoxic chemosensitization of cisplatin by etanidazole in vitro. Proc. Vet. Cancer Soc., 14: 63-64, 1994.
5. Hahn, K. A., Hurd, C., and Cantwell, H. D. Single phase methylene diphosphate bone scintigraphy in the diagnostic evaluation of dogs with osteosarcoma. J. Am. Vet. Med. Assoc., 196: 1483-1486, 1990.
6. Frazier, D. L., and Hahn, K. A. Cisplatin. In: K. A. Hahn and R. C. Richardson (eds.), Cancer Chemotherapy, A Veterinary Handbook, pp. 92-93. Philadelphia, PA: Williams & Wilkins, 1995.
7. Hahn, K. A., Panjehpour, M., and Lu, X. Fluence-dependent induction of micronuclei by aluminum phthalocyanine tetrasulfonate-mediated photodynamic therapy. Photochem. Photobiol., 63: 117-122, 1996.
8. Fenech, M., and Morley, A. A. Cytokinesis-block micronucleus method in human lymphocytes: effect of in vivo ageing and low dose X-irradiation. Mutat. Res., 161: 193-198, 1986.
9. Shibamoto, Y., Streffer, C., Fuhrmann, C., and Budach, V. Tumor radiosensitivity prediction by the cytokinesis-block micronucleus assay. Radiat. Res., 128: 293-300, 1991.
10. Rodilla, V., Pellicer, J. A., Pertusa, J., and Mothersill, C. Induction of micronucleated and binucleate cells in Chinese hamster ovary (CHO) cells by cis-diamminedichloroplatinum (II): a morphological and morphometric study. Mutat. Res., 241: 115-124, 1990.
11. Steel, R. G. D., and Torrie, J. H. Observations. In: R. G. D. Steel and J. H. Torrie (eds.). Principles and Procedures of Statistics, pp. 8-38. New York, NY: McGraw-Hill, 1980.
12. Brodey, R. S. The use of naturally occurring cancer in domestic animals for research into human cancer: general considerations and a review of canine skeletal osteosarcoma. Yale J. Biol. Med., 52: 345-361, 1979.
13. Misdorp, W., and Hart, A. A. M. Some prognostic and epidemiologic factors in canine osteosarcoma. J. Natl. Cancer Inst., 62: 537-545, 1979.
14. Spodnick, G. J., Berg, J., Rand, W. M., Schelling, S. H., Couto, G., Harvey, H. J., Henderson, R. A., MacEwen, E. G., Mauldin, N., McCaw, D. L., Moore, A. S., Morrison, W., Norris, A. M., O'Bradovich, J., O'Keefe, D. A., Page, R., Ruslander, D., Klausner, J., Straw, R., Thompson, J. P., and Withrow, S. J. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). J. Am. Vet. Med. Assoc., 200: 995-1000, 1992.
15. Jaffe, N., Raymond, A. K., Ayala, A., Carrasco, C. H., Wallace, S., Robertson, R., Griffiths, M., and Wang, Y. M. Effect of cumulative courses of intraarterial cis-diamminodichloroplatinum-II on the primary tumor in osteosarcoma. Cancer (Phila.), 63: 63-67, 1989.
16. O'Brien, M. G., Withrow, S. J., and Straw, R. C. Recent advances in the treatment of canine appendicular osteosarcoma. Comp. Cont. Educ. Small Anim. Pract., 15: 939-948, 1993.
17. Knapp, D. W., Richardson, R. C., Bonney, P. L., and Hahn, K. A. Cisplatin therapy in 41 dogs with malignant tumors. J. Vet. Intern. Med., 2: 41-46, 1988.
18. Reed, E., and Kohn, K. W. Platinum analogs. In: B. A. Chabner (ed.). Cancer Chemotherapy - Principles and Practices, pp. 465-490. Philadelphia, PA: J. B. Lippincott Co., 1990.
19. 2) in 31 dogs. Proc. Vet. Cancer Soc., 43-44, 1994.
20. Reed, E., Parker, R. J., Gill, I., Bicher, A., Dabholkar, M., Vionnet, J. A., Bostick-Bruton, F., Tarone, R., and Muggia, F. M. Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies. Cancer Res., 53: 3694-3699, 1993.
21. Heddle, J. A., Cimino, M. C, Hayashi, M., Romagna, F., Shelby, M. D., Tucker, J. D., Vanparys, P. H., and MacGregor, J. T. Micronuclei as an index of cytogenetic damage: past, present, and future. Environ. Mol. Mutagen., 18: 227-291, 1991.